Anti-hedger Newmont ups the ante in Normandy bid

Newmont’s latest bid for Normandy, equivalent to A$1.90 per share, is around 15% higher than that of arch-rival, South Africa's AngloGold. The South African gold miner’s bid, equivalent to A$1.64 per share, was made in September, and the firm will now either have to make a counter bid or admit defeat given the expectation that Normandy’s board would recommend Newmont’s bid to its shareholders.

Newmont is keen to remove Normandy's present hedging strategy, saying it would unwind hedge positions when economically attractive.Newmont’s policy of not hedging is a de facto bet that gold prices will rise in the near future. Gold is currently priced at around $275 per ounce, and Normandy's hedges currently lock in forward prices until 2010 on around eight million ounces of gold at around $304 per ounce.

Many gold investors and miners have hedged their gold positions and future production by selling a future price using options or futures just beyond the current spot price. But this assumption that gold prices will continue to be range-bound leaves such positions susceptible to large losses if the gold price spikes. But such a surge in prices would mean Newmont’s anti-hedging policy would bolster its profits.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Smarter trading in a fragmented world

FX Week recently hosted a webinar in partnership with Refinitiv to ask foreign exchange industry leaders to discuss geopolitical challenges, market changes and developments, and evolving technologies, and how they have shaped forex markets in Asia

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here